Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells 12,032 Shares of Stock

Key Points

• Alignment Healthcare insider Andreas Wagner sold 12,032 shares for a total of $198,167.04, resulting in a 5.90% decrease in his position.
• The company's stock is currently trading at $15.58 after a decline of 1.6%, with a 52-week range between $8.65 and $21.06.
• Analysts maintain a moderate outlook with an average price target of $18.83, and upgrades include a "strong-buy" rating from Stephens and "overweight" from KeyCorp.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Andreas P. Wagner sold 12,032 shares of the firm's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $16.47, for a total transaction of $198,167.04. Following the completion of the sale, the insider owned 192,043 shares of the company's stock, valued at $3,162,948.21. This trade represents a 5.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Alignment Healthcare Price Performance

Alignment Healthcare stock traded up $0.04 during midday trading on Friday, reaching $16.36. The company's stock had a trading volume of 1,760,791 shares, compared to its average volume of 2,964,395. Alignment Healthcare, Inc. has a fifty-two week low of $8.65 and a fifty-two week high of $21.06. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The stock's 50 day simple moving average is $13.93 and its 200 day simple moving average is $15.34. The firm has a market capitalization of $3.24 billion, a PE ratio of -58.43 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. During the same quarter last year, the company earned ($0.13) earnings per share. Alignment Healthcare's quarterly revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Institutional Investors Weigh In On Alignment Healthcare

A number of hedge funds have recently bought and sold shares of the business. State of Wyoming grew its stake in Alignment Healthcare by 133.9% during the 2nd quarter. State of Wyoming now owns 20,406 shares of the company's stock valued at $286,000 after purchasing an additional 11,683 shares in the last quarter. Caxton Associates LLP acquired a new stake in Alignment Healthcare during the 2nd quarter valued at approximately $240,000. Tower Research Capital LLC TRC grew its stake in Alignment Healthcare by 2,098.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 19,679 shares of the company's stock valued at $276,000 after purchasing an additional 18,784 shares in the last quarter. Tidal Investments LLC grew its stake in Alignment Healthcare by 4.9% during the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock valued at $253,000 after purchasing an additional 852 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC acquired a new stake in Alignment Healthcare during the 2nd quarter valued at approximately $2,039,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on ALHC shares. KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target on the stock in a research note on Monday, August 25th. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their price objective for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. UBS Group increased their target price on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. Finally, Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.